Swara Baby Products Secures SEBI Approval to Raise Rs 1,000 Crore via IPO

Contract manufacturer Swara Baby Products Limited has received regulatory clearance from the Securities and Exchange Board of India (SEBI) to raise ₹1,000 crore through an initial public offering (IPO). The company, which is promoted by FirstCry parent Brainbees Solutions Limited, had submitted its draft red herring prospectus (DRHP) in July.

Issue Structure and Selling Shareholders

The proposed ₹1,000 crore public issue consists of an equal split between fresh capital generation and secondary share sales:

• A fresh issue of equity shares aggregating up to ₹500 crore.
• An Offer for Sale (OFS) of up to ₹500 crore by existing promoter shareholders.

Under the OFS component, Brainbees Solutions Limited—which held a 76.59% stake at the time of the draft filing—will divest equity shares worth up to ₹300 crore. Promoter entity Anadya Bon Merchari LLP will offload shares valued at up to ₹200 crore. In addition, Swara Baby Products may evaluate a pre-IPO placement of up to ₹100 crore in consultation with its merchant bankers. If completed, the fresh issue component will be reduced proportionally.

JM Financial and Avendus Capital are serving as the book-running lead managers for the issue, while MUFG Corporate Services India is the registrar. The equity shares are proposed to list on both the BSE and the NSE.

Utilization of IPO Proceeds

The net proceeds from the fresh capital raise will be channeled primarily toward capital expenditure and deleveraging:

• Manufacturing Expansion: ₹198.2 crore will be utilized to set up a new production facility at Pithampur in Madhya Pradesh. The facility forms part of an overall ₹558.47 crore capacity expansion program designed to scale output across baby diapers, adult incontinence products, and sanitary pads.
• Debt Repayment: ₹100 crore will be deployed toward prepayment or repayment of outstanding borrowings availed by the company.
• Subsidiary Support: ₹27.5 crore will be infused into wholly owned subsidiaries—Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Private Limited (KAEHPL)—to retire debt obligations.
• Inorganic Growth & Corporate Needs: The remaining funds will be deployed toward opportunistic acquisitions and general corporate purposes.

Business Footprint and Financial Performance

Established in 2018, Swara Baby Products has evolved into India's largest contract manufacturer of disposable hygiene products by value. The company operates 20 production lines across four facilities located in Pithampur and Indore, Madhya Pradesh. Its product portfolio covers baby diapers (both pant-style and tape-style), adult incontinence wear, and feminine hygiene items like sanitary napkins and panty liners.

Beyond white-label manufacturing for major brand owners such as Brainbees Solutions, Piramal Pharma, and Himalaya Wellness Company, Swara Baby sells its own consumer-facing labels, Cuddles and Shield, through modern trade and e-commerce platforms.

For the financial year ended March 31, 2026, the company reported a total income of ₹1,212.44 crore, compared to ₹959.66 crore in FY25 and ₹766.60 crore in FY24. Profit after tax (PAT) rose to ₹95.59 crore in FY26 from ₹80.67 crore in the previous fiscal year, reflecting expanding operational scale in India's underpenetrated hygiene market.

Tags: Swara Baby Products Brainbees Solutions FirstCry SEBI IPO FMCG